Comparing Laringocel® and C‑MAC® video laryngoscopes for placing breathing tubes during elective surgery
Estimation of the Non-Inferiority of the Laringocel® Videolaryngoscope Compared With the C-MAC D-BLADE (Karl Storz®) for First-Attempt Intubation in Adult Patients Undergoing Elective Surgery
This comparison will test whether the Colombian Laringocel® video laryngoscope works as well as the C‑MAC D‑Blade® to help anesthesiologists place breathing tubes in adults having elective surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 252 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Universidad de Antioquia Academic / other |
| Locations | 1 site (Medellín, Antioquia) |
| Trial ID | NCT07239141 on ClinicalTrials.gov |
What this trial studies
This randomized, single-center trial will enroll 252 adults undergoing elective surgery at Hospital Alma Máter de Antioquia and assign them 1:1 to intubation with either Laringocel® or the C‑MAC D‑Blade®. Only trained anesthesiologists will perform orotracheal intubation using the assigned video laryngoscope. The primary outcome is first-attempt intubation success (first-pass rate), with procedural details and safety data recorded for each case. The goal is to determine whether the locally made Laringocel® performs similarly to the widely used C‑MAC device and could offer a lower-cost option.
Who should consider this trial
Good fit: Adults aged 18 and older scheduled for elective surgery under general anesthesia who require single-lumen orotracheal intubation and meet standard preoperative fasting and anesthesia criteria.
Not a fit: Patients with an anticipated difficult airway (more than two anatomical risk factors) or those undergoing non-elective/emergency procedures are excluded and unlikely to benefit from this comparison.
Why it matters
Potential benefit: If Laringocel® performs similarly, it could offer hospitals a more affordable video laryngoscope option without sacrificing first-attempt intubation success.
How similar studies have performed: Video laryngoscopy is well established and many devices have improved first-pass intubation rates in prior trials, but direct randomized comparisons involving the Laringocel® are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients 18 years of age or older * Patients scheduled for elective surgery under general anesthesia * Patients requiring single-lumen orotracheal intubation * Patients compliant with the anesthetic indication and standard preoperative fasting requirements Exclusion Criteria: * Patients with an anticipated difficult airway (more than two anatomical risk factors for difficult airway) * Patient refusal to participate in the study via informed consent
Where this trial is running
Medellín, Antioquia
- Hospital Alma Máter de Antioquia — Medellín, Antioquia, Colombia (Recruiting)
Study contacts
- Study coordinator: Gabriel R Muñoz Miranda, MD, MSc (candidate)
- Email: gabrielr.munozm@udea.edu.co
- Phone: +57 3187162895
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.